DEA Extends Telehealth Flexibilities for Controlled Substance Prescribing: What This Means for Providers and Patients
The landscape of telehealth has undergone a monumental transformation in the last few years, driven in large part by the COVID-19 pandemic. Telehealth has...
Pinnacle Treatment Centers Expands Access to Methadone for Opioid Use Disorder in California via Telehealth: A Game-Changer in the Fight Against the Opioid Epidemic
California, like many states across the U.S., has been grappling with a devastating opioid crisis. With overdose deaths on the rise and opioid use...
Acadia Healthcare’s Strategic Expansion: Strengthening its Position in the Opioid Treatment Landscape
Acadia Healthcare (Nasdaq: ACHC), the largest behavioral health provider in the United States, continues to execute its ambitious mergers and acquisitions (M&A) strategy, cementing...
The Critical Role of Medication for Opioid Use Disorder: Who’s Getting Help—And Who’s Not
More than 2.7 million people in the U.S. live with opioid use disorder (OUD), yet a staggering 86% of them do not receive Medication...
The Power of Diversification in ABA Therapy: A Sustainable Business Model for Autism Treatment
Applied Behavioral Analysis (ABA) therapy has become a cornerstone in the treatment of autism, known for its effectiveness in helping individuals build and strengthen...
Doreen Granpeesheh’s Vision for a Resilient and Growth-Focused Center for Autism & Related Disorders (CARD)
Over the past year, Doreen Granpeesheh, the founder of the Center for Autism & Related Disorders (CARD), has been hard at work revitalizing the...
